Avaxia Biologics Receives $1,005,777 New Financing

  • Feed Type
  • Date
    7/21/2015
  • Company Name
    Avaxia Biologics
  • Mailing Address
    128 Spring Street Lexington, MA 02421 USA
  • Company Description
    Avaxia is developing oral antibody products for diseases and disease targets that can be reached through the mouth and the gastrointestinal tract.
  • Website
    http://www.avaxiabiologics.com
  • Transaction Type
    Debt
  • Transaction Amount
    $1,005,777
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy